Nuvectra News Releases http://investors.nuvectramed.com/ Nuvectra News Releases en Nuvectra® to Participate in Two Upcoming Investor Conferences http://investors.nuvectramed.com/news-releases/news-release-details/nuvectrar-participate-two-upcoming-investor-conferences-0 PLANO, Texas , June 12, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that members of management are scheduled to participate in two upcoming investor conferences in New York, NY .                             Event:         Wed, 12 Jun 2019 16:05:00 -0400 Nuvectra News Releases 8911 Nuvectra Files Regulatory Submission with FDA for Algovita® Full-Body MR-Conditional Approval http://investors.nuvectramed.com/news-releases/news-release-details/nuvectra-files-regulatory-submission-fda-algovitar-full-body-mr PLANO, Texas , June 11, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it has filed its regulatory submission with the U.S. Food and Drug Administration ( FDA ) for full-body MR-conditional approval for the Company’s Tue, 11 Jun 2019 16:05:00 -0400 Nuvectra News Releases 8891 Nuvectra Highlights Positive Preliminary Algovita® Clinical Data at the INS 14th Annual World Congress http://investors.nuvectramed.com/news-releases/news-release-details/nuvectra-highlights-positive-preliminary-algovitar-clinical-data Data Illustrates Below Industry Average Lead Fracture and Migration Rates PLANO, Texas ,, May 30, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today preliminary Algovita ® clinical data from its U.S. Thu, 30 May 2019 08:30:00 -0400 Nuvectra News Releases 8881 Nuvectra® Announces Departure of COO & CFO Walter Z. Berger http://investors.nuvectramed.com/news-releases/news-release-details/nuvectrar-announces-departure-coo-cfo-walter-z-berger Appoints Jennifer Kosharek as Interim CFO PLANO, Texas , May 16, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, today announced that Walter Z. Berger has resigned as Nuvectra’s Chief Operating Officer and Chief Financial Officer to pursue Thu, 16 May 2019 09:00:00 -0400 Nuvectra News Releases 8856 Nuvectra® Reports First Quarter 2019 Financial Results http://investors.nuvectramed.com/news-releases/news-release-details/nuvectrar-reports-first-quarter-2019-financial-results PLANO, Texas , May 01, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today financial results for the first quarter ended March 31, 2019 . Recent Business Highlights Increased Algovita ® revenues 22% YoY to $11.0 million Providing Wed, 01 May 2019 16:01:00 -0400 Nuvectra News Releases 8806 Nuvectra to Report First Quarter 2019 Financial Results on May 1, 2019 http://investors.nuvectramed.com/news-releases/news-release-details/nuvectra-report-first-quarter-2019-financial-results-may-1-2019 PLANO, Texas , April 22, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it will release its financial results for the first quarter ended March 31, 2019 on Wednesday, May 1, 2019 after market close. Mon, 22 Apr 2019 16:05:00 -0400 Nuvectra News Releases 8796 Nuvectra® Appoints Anthony P. Bihl, III as New Chairman of the Board http://investors.nuvectramed.com/news-releases/news-release-details/nuvectrar-appoints-anthony-p-bihl-iii-new-chairman-board Elects Jane J. Song to the Board of Directors PLANO, Texas , March 25, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, today announced the appointment of Anthony P. Bihl, III as Chairman of the Board of Directors, following Dr. Joseph A. Mon, 25 Mar 2019 08:01:00 -0400 Nuvectra News Releases 8661 Nuvectra® Reports Fourth Quarter and Full Year 2018 Financial Results http://investors.nuvectramed.com/news-releases/news-release-details/nuvectrar-reports-fourth-quarter-and-full-year-2018-financial Record Fourth Quarter & Full Year 2018 Algovita® Sales of $14.1 million and $47.1 million, Up 36% and 84% YoY Respectively PLANO, Texas , Feb. 28, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today financial results for the Thu, 28 Feb 2019 16:01:00 -0500 Nuvectra News Releases 8476 Nuvectra® to Present at 39th Annual Cowen Healthcare Conference http://investors.nuvectramed.com/news-releases/news-release-details/nuvectrar-present-39th-annual-cowen-healthcare-conference PLANO, Texas , Feb. 26, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that Fred Parks , PhD, Chief Executive Officer, and Walter Berger , Chief Operating Officer & Chief Financial Officer, are scheduled to present at the Tue, 26 Feb 2019 08:31:06 -0500 Nuvectra News Releases 8471 Nuvectra to Report Fourth Quarter and Full Year 2018 Financial Results on February 28, 2019 http://investors.nuvectramed.com/news-releases/news-release-details/nuvectra-report-fourth-quarter-and-full-year-2018-financial PLANO, Texas , Feb. 19, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it will release its financial results for the fourth quarter and full year ended December 31, 2018 on Thursday, February 28, 2019 after market close. Tue, 19 Feb 2019 08:30:36 -0500 Nuvectra News Releases 8466